ECSP014057A - STEROID COMPOUNDS FOR SELECTIVE MODIFICATION OF THE ACTIVITY OF STROGEN RECEIVERS - Google Patents

STEROID COMPOUNDS FOR SELECTIVE MODIFICATION OF THE ACTIVITY OF STROGEN RECEIVERS

Info

Publication number
ECSP014057A
ECSP014057A ECSP014057A ECSP014057A EC SP014057 A ECSP014057 A EC SP014057A EC SP014057 A ECSP014057 A EC SP014057A EC SP014057 A ECSP014057 A EC SP014057A
Authority
EC
Ecuador
Prior art keywords
selective modification
activity
strogen
receivers
alkenyl
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Hubert Jan Jozef Loozen
Original Assignee
Nv Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nv Organon filed Critical Nv Organon
Publication of ECSP014057A publication Critical patent/ECSP014057A/en

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

La invención describe un compuesto esterioide que tiene la fórmula I: (gráfico), donde los enlaces con línea representan dobles enlaces opcionales; R6 es H, =CH2, -CH3 ó -CH2-CH3; R7 es H, C1-4- alquilo C2-5 alquenilo o C2-5 alquinilo, donde el grupo alquilo, alquenilo o alquinilo puede estar sustituido con 1 a 3 átomos de halógeno, elegidos independientemente del grupo de átomos de flúor o cloro; E representa, junto con los átomos de carbono 16 y 17 del esqueleto del esteroide, un anillo de cuatro a siete miembros, estando dicho anillo y en configuración cis con respecto al esqueleto del esteroide, comprendido opcionalmente uno o dos enlaces endocíclicos; o un profármaco del mismo. Estos compuestos pueden usarse en terapia y en métodos para la modificación selectiva de la actividad de los receptores de estrógenos.The invention describes an sterioid compound having the formula I: (graphic), where the line links represent optional double bonds; R6 is H, = CH2, -CH3 or -CH2-CH3; R7 is H, C1-4-C2-5 alkenyl or C2-5 alkynyl, where the alkyl, alkenyl or alkynyl group may be substituted with 1 to 3 halogen atoms, independently selected from the group of fluorine or chlorine atoms; E represents, together with carbon atoms 16 and 17 of the steroid skeleton, a four to seven member ring, said ring being in cis configuration with respect to the steroid skeleton, optionally comprised of one or two endocyclic bonds; or a prodrug thereof. These compounds can be used in therapy and in methods for the selective modification of estrogen receptor activity.

ECSP014057 2000-06-06 2001-05-04 STEROID COMPOUNDS FOR SELECTIVE MODIFICATION OF THE ACTIVITY OF STROGEN RECEIVERS ECSP014057A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EM20198600 2000-06-06

Publications (1)

Publication Number Publication Date
ECSP014057A true ECSP014057A (en) 2002-01-25

Family

ID=40410321

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP014057 ECSP014057A (en) 2000-06-06 2001-05-04 STEROID COMPOUNDS FOR SELECTIVE MODIFICATION OF THE ACTIVITY OF STROGEN RECEIVERS

Country Status (1)

Country Link
EC (1) ECSP014057A (en)

Similar Documents

Publication Publication Date Title
PE20001551A1 (en) DERIVATIVES OF BIARYLIC ETHER AS INHIBITORS OF MONOAMINE RECAPTATION FOR THE TREATMENT OF CNS DISORDERS
HN1998000157A (en) PROSTAGLANDIN AGONISTS
ES2162198T3 (en) STROGEN AGENTS.
CO4700455A1 (en) TETRACYCLIC DERIVATIVES AND THE PROCESS FOR THEIR PREPARATION
DK0640592T3 (en) N-acylated tricyclic azaheter rings useful as vasopressin antagonists
BR9915938A (en) Pyrimidine derivatives replaced by aryl and heterocyclyl as anticoagulants
AR005672A1 (en) DERIVATIVES OF DISTAMICINE, PROCESS TO PREPARE THEM, AND THEIR USE AS ANTI-TUMOR AND ANTIVIRAL AGENTS.
AR057987A1 (en) CB1 AGONIST COMPOUNDS (CANNABINOID RECEPTOR)
NO20041503L (en) Pyrimidinones such as melanin concentrating hormone receptor 1
DK1337518T3 (en) Piperazinylpyrazine Compounds as Antagonists of the Serotonin-5-HT2 Receptor
GT199900217A (en) COMPOUNDS USED IN THE TREATMENT OF INFLAMMATORY MATTERS.
EA200101177A1 (en) INDOL DERIVATIVES AS PROGESTERONE ANTAGONISTS
BR0012489A (en) Compound, pharmaceutical composition, use of a compound, and, kit for male contraception
CO4950531A1 (en) ANALOGS OF VITAMIN D3 PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
EA200300716A1 (en) HETEROCYCLILALKILINDOL OR-ASAINDOL COMPOUNDS AS LIGAND 5-HYDROXYTRIPTAMINE-6
ES2183340T3 (en) PROCEDURE FOR THE PREPARATION OF COMPOUNDS OF 4-BROMOMETIL-BIFENILO.
GT199900011A (en) NEW DERIVATIVES OF DIHYDROXYHEXANIC ACID
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
DK1051177T3 (en) Steroidal 3-O-Sulfamate derivatives as inhibitors of oestrone sulfatase
SE9801494D0 (en) Novel use
EA200000910A1 (en) AZABICYCLIC LIGANDS OF 5HT1 RECEPTORS
FR2379581A1 (en) FLUORESCENT COLORANTS DERIVED FROM COUMARINE
DK0977716T3 (en) Use of alcohols as additives for plaster and / or mortar
EA200100517A1 (en) ANTAGONISTS 5HT1 FOR ANTIDEPRESSANT THERAPY
CO5251441A1 (en) STEROID COMPOUNDS CONTAINING A CYCLOPROPAN RING